NewAmsterdam Pharma Co N.V. (NAMSW) Financial Forecast
United States · Industrial & Consumer Products · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-28.29%
2025 (actual)
ROA
-24.95%
2025 (actual)
Gross Margin
100%
2025 (actual)
Net Margin
-905.74%
2025 (actual)
Total Assets
$769,284.00K
2025 (actual)
Net Income
-$203,819.00K
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+100 pt
Company
Sector average
ROA
-33.2 pt
Company
Gross Margin
+0 pt
Company
Sector average
Total Assets
-40%
Company
Sector average (own scale)
Net Income
-29.3%
Company
Detailed data
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NewAmsterdam Pharma Co N.V.? It covers the balance sheet, income statement, cash flow and Equlion model projections.